At 6.6% CAGR, Europe Positive Airway Pressure (PAP) Devices Market is Projected to be Worth US$ 2,997.83 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Europe positive airway pressure (PAP) devices market was valued at US$ 1,803.88 million in 2023 and is expected to reach US$ 2,997.83 million by 2031, registering a CAGR of 6.6% from 2023 to 2031. Growing shift toward home healthcare and increasing awareness of respiratory diseases are among the critical factors attributed to the Europe positive airway pressure (PAP) devices market expansion.

Patients largely prefer availing treatment in the convenience and comfort of their homes over clinical settings. PAP devices work well in home-care settings to treat sleep apnea and other respiratory disorders, which relieves the burden on healthcare facilities and promotes consistent use of PAP devices. Sleep apnea and many other respiratory disorders require long-term therapy. By providing long-term, at-home solutions, PAP devices promote cost-effectiveness.

The shift toward home healthcare directly drives the sales of PAP devices designed for home use. Thus, manufacturers focus on producing user-friendly, portable, and efficient devices for this expanding market. For example, ResMed manufactured the AirMini Portable CPAP used in home care. It influences the market by pushing innovation, creating the need for home-use devices, and improving access to respiratory care in developed and developing nations. As healthcare systems are increasingly prioritizing home-based treatment options, this inclination is predicted to continue.

On the contrary, product recall hampers the growth of Europe positive airway pressure (PAP) devices market.

Based on product type, the Europe positive airway pressure (PAP) devices market is segmented into automatic positive airway pressure (APAP) devices, continuous positive airway pressure (CPAP) devices, and bilevel positive airway pressure (BiPAP) devices. The continuous positive airway pressure (CPAP) devices segment held 69.0% share of the Europe positive airway pressure (PAP) devices market in 2023, amassing US$ 1,244.20 million. It is projected to garner US$ 2,196.48 million by 2031 to expand at 7.4% CAGR during 2023–2031.

Based on application, the Europe positive airway pressure (PAP) devices market is segmented into chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea segment held 77.7% share of the Europe positive airway pressure (PAP) devices market in 2023, amassing US$ 1,401.56 million. It is projected to garner US$ 2,418.65 million by 2031 to expand at 7.1% CAGR during 2023–2031.

Based on end user, the Europe positive airway pressure (PAP) devices market is segmented into hospitals, ambulatory surgical centers, home care, and rehabilitation centers. The hospitals segment held 55.6% share of the Europe positive airway pressure (PAP) devices market in 2023, amassing US$ 1,003.10 million. It is projected to garner US$ 1,854.20 million by 2031 to expand at 8.0% CAGR during 2023–2031.

Based on country, the Europe positive airway pressure (PAP) devices market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany held 25.3% share of Europe positive airway pressure (PAP) devices market in 2023, amassing US$ 456.84 million. It is projected to garner US$ 813.39 million by 2031 to expand at 7.5% CAGR during 2023–2031.

Key players operating in the positive airway pressure (PAP) devices market are ICU Medical Inc; React Health (Formerly 3B Medical, Inc); Fisher & Paykel Healthcare Corp Ltd; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; Dragerwerk AG & Co KGaA; ResMed Inc; Vyaire Medical Inc; Wellell Inc; Armstrong Medical Ltd; Löwenstein Medical UK Ltd.; BMC Medical Co Ltd; and Narang Medical Limited., among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com